Correlation Between Kronos Bio and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Kronos Bio and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Centessa Pharmaceuticals.
Diversification Opportunities for Kronos Bio and Centessa Pharmaceuticals
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Kronos and Centessa is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Kronos Bio i.e., Kronos Bio and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kronos Bio and Centessa Pharmaceuticals
Given the investment horizon of 90 days Kronos Bio is expected to under-perform the Centessa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Kronos Bio is 1.08 times less risky than Centessa Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1,551 in Centessa Pharmaceuticals PLC on August 28, 2024 and sell it today you would earn a total of 159.00 from holding Centessa Pharmaceuticals PLC or generate 10.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kronos Bio vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| Kronos Bio |
| Centessa Pharmaceuticals |
Kronos Bio and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kronos Bio and Centessa Pharmaceuticals
The main advantage of trading using opposite Kronos Bio and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| Kronos Bio vs. Cyclerion Therapeutics | Kronos Bio vs. Larimar Therapeutics | Kronos Bio vs. Addex Therapeutics | Kronos Bio vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |